Delivery Order SPE2DB22D1017-SPE2DB25FE8QH
Award Date
11/5/24
Potential Completion Date
11/6/24
Potential Value
$5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,863.00, is for the delivery of Dupixent 200 mg/1.14 ml pens. The contract is a Firm Fixed Price Delivery Order with a completion date of November 3, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $31,119.15, is a delivery order for the supply of Dupixent 300 mg/2 ml pens. The contract has a firm fixed price pricing type and runs through June 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $47,157.90 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of July 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a wide range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Dupixent 300 mg/2 ml pens, with a ceiling value of $18,122.85 and a completion date of June 25, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $17,738.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Dupixent 300 mg/2 ml pens, with an ultimate completion date of April 23, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $6,991.37, is for the delivery of Dupixent 200 mg/1.14 ml pens to support military healthcare programs. The contract is a firm fixed-price delivery order with an ultimate completion date of April 1, 2025. There is no set-aside designation for this award. In addition to this specific contract,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,619.72, is a delivery order for Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product. The contract has an ultimate completion date of July 29, 2024 and uses a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price, valued at $24,312.56, to provide Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of March 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,028.11 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens to support military healthcare programs. The contract has an ultimate completion date of March 28, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,976.40, is for the delivery of Dupixent 300 mg/2 ml pens to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of May 13, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...